SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001140361-21-013549
Filing Date
2021-04-20
Accepted
2021-04-20 20:13:26
Documents
2
Period of Report
2021-04-16

Document Format Files

Seq Description Document Type Size
1 FORM 3 form3.html 3  
1 FORM 3 form3.xml 3 1601
2 EXHIBIT 24 brhc10023379_ex24.htm EX-24 10137
  Complete submission text file 0001140361-21-013549.txt   13467
Mailing Address 140 58TH STREET, BUILDING A SUITE 2100 BROOKLYN NY 11220
Business Address 140 58TH STREET, BUILDING A SUITE 2100 BROOKLYN NY 11220 (212) 582-1199
Brooklyn ImmunoTherapeutics, Inc. (Issuer) CIK: 0000748592 (see all company filings)

IRS No.: 311103425 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O BROOKLYN IMMUNOTHERAPEUTICS, INC. 140 58TH STREET, BUILDING A, SUITE 2100 BROOKLYN NY 11220
Business Address
Federoff Howard J. (Reporting) CIK: 0001857261 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-11460 | Film No.: 21839225